Feds Float Drop Of Preterm Birth Drug Approval, Women Say
A group of women challenging AMAG Inc.'s marketing and sale of a drug advertised as reducing the chance of preterm births has told a New Jersey federal court that a U.S....To view the full article, register now.
Already a subscriber? Click here to view full article